Literature DB >> 12007524

Targeting afferent hyperexcitability for therapy of the painful bladder syndrome.

Naoki Yoshimura1, Satoshi Seki, Michael B Chancellor, William C de Groat, Tomohiro Ueda.   

Abstract

The involvement of C-fiber afferent pathways in urinary frequency and pain associated with painful bladder syndrome raises the possibility of multiple targets for the treatment of this disease. Using an in vivo measurement of bladder activity as well as whole-cell patch clamp recording techniques to examine the properties of bladder afferent neurons in animal models of chronic cystitis, we have documented that tetrodotoxin-resistant sodium channels encoded by the Na(v) 1.8 (PN3/SNS) gene and nitric oxide acting via a cyclic guanosine monophosphate (cGMP)-dependent mechanism are important in modulating bladder pain responses. Thus, suppression of C-fiber afferent nerve activity by blocking specific sodium channels, elevating nitric oxide levels, or activating cGMP-dependent pathways might represent novel strategies for the treatment of symptoms in patients with painful bladder syndrome. Another treatment strategy is suppression of release or activity of proinflammatory agents that can cause normally unexcitable C-fiber afferents to become hyperactive or hyperexcitable. This approach to management of bladder pain was tested in patients with painful bladder syndrome by examining the effectiveness of the antiallergic agent suplatast tosilate (IPD-1151T), which suppresses urinary frequency in a rat model of cystitis. IPD-1151T is an immunoregulator that suppresses cytokine production in T-helper 2 cells and inhibits immunoglobulin E antibody formation and antigen-induced histamine release from mast cells. Preliminary data from an open-label clinical trial showed that 16 of 23 (70%) patients responded to treatment with IPD-1151T (300 mg/day orally for 12 months). The finding that expression of platelet-derived endothelial cell growth factor, which can activate mast cells, was lower in the bladder of responders than nonresponders indicates that bladder levels of platelet-derived endothelial cell growth factor may be a useful marker for this disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12007524     DOI: 10.1016/s0090-4295(01)01639-9

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  32 in total

Review 1.  Selection of ideal candidates for neuromodulation in refractory overactive bladder.

Authors:  Ravi Kacker; Anurag K Das
Journal:  Curr Urol Rep       Date:  2010-11       Impact factor: 3.092

2.  Recovery of urothelial mediator release but prolonged elevations in interleukin-8 and nitric oxide secretion following mitomycin C treatment.

Authors:  Sung Hyun Kang; Russ Chess-Williams; Shailendra Anoopkumar-Dukie; Catherine McDermott
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-02-03       Impact factor: 3.000

Review 3.  Bladder sensory physiology: neuroactive compounds and receptors, sensory transducers, and target-derived growth factors as targets to improve function.

Authors:  Eric J Gonzalez; Liana Merrill; Margaret A Vizzard
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-04-23       Impact factor: 3.619

4.  Sensory neurone-specific receptor-mediated regulation of micturition reflex in urethane-anaesthetized rats.

Authors:  Masashi Honda; Atsushi Takenaka; Seiya Inoue; Michael B Chancellor; Naoki Yoshimura
Journal:  BJU Int       Date:  2011-07-05       Impact factor: 5.588

5.  Recurrent inhibition of the bladder C fibre reflex in the cat and its response to naloxone.

Authors:  L Mazières; C H Jiang; S Lindström
Journal:  J Physiol       Date:  2006-06-29       Impact factor: 5.182

Review 6.  Neural control of the lower urinary tract.

Authors:  William C de Groat; Derek Griffiths; Naoki Yoshimura
Journal:  Compr Physiol       Date:  2015-01       Impact factor: 9.090

Review 7.  Bladder afferent hyperexcitability in bladder pain syndrome/interstitial cystitis.

Authors:  Naoki Yoshimura; Tomohiko Oguchi; Hitoshi Yokoyama; Yasuhito Funahashi; Satoru Yoshikawa; Yoshio Sugino; Naoki Kawamorita; Mahendra P Kashyap; Michael B Chancellor; Pradeep Tyagi; Teruyuki Ogawa
Journal:  Int J Urol       Date:  2014-04       Impact factor: 3.369

8.  Bladder hyperactivity and increased excitability of bladder afferent neurons associated with reduced expression of Kv1.4 alpha-subunit in rats with cystitis.

Authors:  Yukio Hayashi; Koichi Takimoto; Michael B Chancellor; Kristin A Erickson; Vickie L Erickson; Tsukasa Kirimoto; Koushi Nakano; William C de Groat; Naoki Yoshimura
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-03-11       Impact factor: 3.619

9.  Chronic pelvic pain syndromes: clinical, urodynamic, and urothelial observations.

Authors:  Charles W Butrick; Dan Sanford; Qingijiang Hou; Jonathan D Mahnken
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-05-21

10.  Blockade of NGF and trk receptors inhibits increased peripheral mechanical sensitivity accompanying cystitis in rats.

Authors:  Simone D Guerios; Zun-Yi Wang; Kyle Boldon; Wade Bushman; Dale E Bjorling
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-04-30       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.